Clinical Trial Update: A Study of HS-20106 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating HS-20106 for anemia due to very low, low, or intermediate-risk myelodysplastic syndromes. The study status is NOT_YET_RECRUITI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Myelodysplastic Syndromes

Drugs mentioned

• HS-20106

Snippet

Sponsor: Hansoh BioMedical R&D Company | Conditions: Myelodysplastic Syndromes, Anemia | Phase 2 | Status: NOT_YET_RECRUITING